India reacts to COVID-19, surging exports with key drug export restrictions — Panjiva
MENU

Panjiva_research_logo

India reacts to COVID-19, surging exports with key drug export restrictions

China 2393 Coronavirus 256 Health Care 194 India 385 U.S. 4229

The Indian government has restricted exports of 13 health care products including acetaminophen, B-complex vitamins, birth control and antibiotics in both powder and pill formats. It’s not clear how the restriction will work but it is arguably one of the most significant non-China supply chain disruptions since the COVID-19 outbreak. Indian exports of the products covered fell 33.6% year over year in the 12 months to Nov. 30. Exports to the U.S. – which represented 11.9% of the total Indian exports including shipments by Sun Pharma and Granules India – were an outlier in seeing an increa...

Copyright © 2020 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.